Magnetic Resonance Enterography in Inflammatory Bowel Diseases
Role of Magnetic Resonance Enterography (MRE) in Assessment of Inflammatory Bowel Diseases.
1 other identifier
observational
30
0 countries
N/A
Brief Summary
Assess the accuracy of magnetic resonance-enterography in predicting the extension, location and characteristics of the small bowel segments affected by Crohn's disease\& determine the diagnostic performance of standard MR enterography in detecting colonic inflammation and investigate MR enterography's ability to grade inflammatory activity and detect intestinal extra intestinal manifestations
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2020
CompletedFirst Posted
Study publicly available on registry
March 27, 2020
CompletedStudy Start
First participant enrolled
April 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedMarch 27, 2020
March 1, 2020
1.9 years
March 25, 2020
March 25, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
comparison of magnetic resonance enterography findings with colonoscopic findings and clinical activity scores of IBD
To investigate MR enterography's ability to detect to the extension, location and characteristics of intestinal segments affected by IBD and grade inflammatory activity in correlation with endoscopic findings.
two years
Eligibility Criteria
subjects of both sexes with different age groups diagnosed to have inflammatory bowel disease
You may qualify if:
- Patients with different age groups and both sex are eligible for our prospective study
- Either they had undergone colonoscopy or colonoscopy was planned, and they have been recently diagnosed with IBD.
- Suspected to have disease relapse.
You may not qualify if:
- Participants are not eligible for our prospective study if they:
- Have evidence of severe or uncontrolled systemic disease that rendered the individual unsuitable for participation.
- Have contraindications to MRE (e.g. allergy to all suitable contrast agents, cardiac pacemaker, severe claustrophobia, an inability to lie flat).
- Had a final diagnosis other than IBD.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal invistigator
Study Record Dates
First Submitted
March 25, 2020
First Posted
March 27, 2020
Study Start
April 1, 2020
Primary Completion
March 1, 2022
Study Completion
April 1, 2022
Last Updated
March 27, 2020
Record last verified: 2020-03